Richard Giltner

Richard Giltner, Director of UNITED THERAPEUTICS Corp, the only company in the record, has 53 filings covering trades from December 6, 2016 to July 9, 2026. The dominant nature is neither purchase nor sale: 30 option exercises, no share grant, 13 other lines, and 10 open-market sales.

Those sales total EUR 7,373,429, with a median of EUR 471,506. One of them is EUR 3,007,874, on November 5, 2024; next are EUR 757,154 on June 24, 2025 and EUR 619,904 on December 6, 2016. No purchase appears.

The record is concentrated in 2019 and 2020 with 11 filings each, against 2 a year from 2016 to 2018 and 1 in 2026. A single filing falls in the last twelve months, not a sale. Filings are published a median of 1 day after the trade.

Within 30 days of Giltner's trades fall those of Christopher Causey (4 market trades, same direction) as well as James Edgemond, Martine A. Rothblatt, Nilda Mesa and Paul A. Mahon (3 each, same direction).